Literature DB >> 7562762

Elevated cancer incidence in patients with dermatomyositis: a population based study.

A Airio1, E Pukkala, H Isomäki.   

Abstract

OBJECTIVE: To study the relationship of polymositis (PM) and dermatomyositis (DM) and cancer in Finland.
METHODS: The medical records of 175 patients with PM and 71 with DM diagnosed between 1969 and 1985 were reviewed. The patients were followed until death or until December 30, 1990 through the files of Statistics Finland and the Finnish Cancer Registry.
RESULTS: Thirty-four cases of cancer were found [standardized incidence ratio (SIR) 2.1, 95% confidence interval 1.4-2.9]. In the PM group the SIR was 1.0 (95% CI 0.5-1.8), and in the DM group 6.5 (95% CI 3.9-10). The relative risk of cancer among DM cases was very high (SIR 26, 12-48) in the first year after DM diagnosis.
CONCLUSION: DM is associated with cancer, but not PM. The risk is high among patients with DM older than 49. Cytotoxic drugs given to DM patients did not increase the risk of malignancies. DM and certain cancers seem to share etiological factors.

Entities:  

Mesh:

Year:  1995        PMID: 7562762

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  45 in total

1.  Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation.

Authors:  Y Zhang; H H Ng; H Erdjument-Bromage; P Tempst; A Bird; D Reinberg
Journal:  Genes Dev       Date:  1999-08-01       Impact factor: 11.361

Review 2.  Chromatin modification and disease.

Authors:  C A Johnson
Journal:  J Med Genet       Date:  2000-12       Impact factor: 6.318

3.  The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth.

Authors:  A Brehm; S J Nielsen; E A Miska; D J McCance; J L Reid; A J Bannister; T Kouzarides
Journal:  EMBO J       Date:  1999-05-04       Impact factor: 11.598

Review 4.  The Chd family of chromatin remodelers.

Authors:  Concetta G A Marfella; Anthony N Imbalzano
Journal:  Mutat Res       Date:  2007-01-21       Impact factor: 2.433

5.  Prognosis and mortality of polymyositis and dermatomyositis patients.

Authors:  A Airio; H Kautiainen; M Hakala
Journal:  Clin Rheumatol       Date:  2006-02-14       Impact factor: 2.980

6.  When myopathy strikes in a cancer patient.

Authors:  Srivalli Gopaluni; Lilian M Thomas; Chirag Shah
Journal:  Gastrointest Cancer Res       Date:  2009-09

7.  Cancer-associated myositis: a 35-year retrospective study of a monocentric cohort.

Authors:  Rossella Neri; Simone Barsotti; Barsotti Simone; Valentina Iacopetti; Giacomo Iacopetti; Pasquale Pepe; Anna d'Ascanio; Antonio Gaetano Tavoni; Marta Mosca; Stefano Bombardieri
Journal:  Rheumatol Int       Date:  2013-12-10       Impact factor: 2.631

8.  Amyopathic dermatomyositis or dermatomyositis-like skin disease: retrospective review of 16 cases with amyopathic dermatomyositis.

Authors:  Hua Cao; Tanvi N Parikh; Jie Zheng
Journal:  Clin Rheumatol       Date:  2009-03-18       Impact factor: 2.980

9.  Incidence of dermatomyositis and clinically amyopathic dermatomyositis: a population-based study in Olmsted County, Minnesota.

Authors:  Margo J Bendewald; David A Wetter; Xujian Li; Mark D P Davis
Journal:  Arch Dermatol       Date:  2010-01

10.  Tonsillar squamous cell carcinoma associated with dermatomyositis: the first 2 cases in Korea.

Authors:  Sung Wan Kim; Ju Sup Shim; Young Gyu Eun; Kee Hwan Kwon
Journal:  Yonsei Med J       Date:  2010-07       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.